For patients with heart failure, a greater focus on medication management may be needed in order to mitigate exacerbations caused by certain drugs.

In agreement with a previous meta-analysis, that was conducted on DPP-4 inhibitors including four studies on alogliptin, [27] this meta-analysis has demonstrated a significant reduction of HbA1c ...